Early or later prophylactic INSURE in preterm infants of less than 30 weeks' gestation

Emel Okulu1, Saadet Arsan, İlke Mungan Akın

  • 1Division of Neonatology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey. emelokulu@gmail.com.

Insights

Early surfactant administration with nasal continuous positive airway pressure (nCPAP) did not reduce the need for mechanical ventilation (MV) in preterm infants. However, early INSURE strategy showed a trend towards shorter respiratory support duration.

Area of Science:

  • Neonatal Medicine
  • Respiratory Physiology
  • Pediatric Critical Care

Background:

  • Premature infants (<30 weeks' gestation) often require respiratory support due to immature lungs.
  • Surfactant replacement therapy and nasal continuous positive airway pressure (nCPAP) are standard care.
  • The optimal timing for surfactant administration (INSURE strategy) remains debated.

Purpose of the Study:

  • To compare an early prophylactic INSURE strategy with early nCPAP versus a later surfactant prophylaxis (15 minutes after birth) with early nCPAP.
  • To assess the impact on the need for mechanical ventilation (MV) in preterm infants.

Main Methods:

  • Randomized trial of infants born at <30 weeks' gestation.
  • Two groups: immediate surfactant prophylaxis vs. surfactant at 15 minutes after birth.
  • All infants received poractant alpha and were managed with T-piece ventilation and transitioned to nCPAP.

Main Results:

  • No significant difference in the primary outcome (need for MV within 3 days) between early and late surfactant groups (20% vs. 16.7%).
  • A significantly shorter duration of total respiratory support (CPAP + MV) was observed in the early surfactant group (96h vs. 309h; P=0.038).
  • Incidence of neonatal morbidities, mortality, and hospitalization duration were similar between groups.

Conclusions:

  • Early prophylactic surfactant administration combined with early nCPAP did not prove superior to later administration in reducing the need for MV.
  • The study identified a potential benefit of the early INSURE strategy in reducing the overall duration of respiratory support.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
51
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
337
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
127